Professional Documents
Culture Documents
2.2 Intangible Assets Lecture 2 2023
2.2 Intangible Assets Lecture 2 2023
2.2 Intangible Assets Lecture 2 2023
IAS 38 Intangible
assets
Lecture 2: Part A
Internally generated intangible assets
and subsequent measurement
Purpose and objective
2 PURPOSE AND OBJECTIVE
Capitalised as Intangible asset when all the following criteria, over and
above normal recognition criteria, are met:
Technical feasible;
Intention to complete and use or sell it;
Have adequate resources to complete the IA and to use or sell it (e.g.
show through business plan or lender’s willingness to fund);
Have the ability to use or sell;
Can establish how it will generate future economic benefits; and
Can reliably measure expenditure attributable to IA during its
development.
Development phase further
advanced than Research
phase and IA can arise from it.
8 INTERNALLY GENERATED IA: RESEARCH AND DEVELOPMENT COSTS
TB 15.6.2.1
IAS 38.59
Examples of development activities include the:
the design, construction and testing of pre ‑production or pre ‑use
prototypes and models;
the design of tools, jigs, moulds and dies involving new technology;
the design, construction and operation of a pilot plant that is not of a scale
economically feasible for commercial production; and
the design, construction and testing of a chosen alternative for new or
improved materials, devices, products, processes, systems or services.
9 INTERNALLY GENERATED IA: RESEARCH AND DEVELOPMENT COSTS
TB 15.6.2.1
IAS 38.65, 68 & 71
How does the accounting treatment of research cost differ from that of
development cost?
Research costs
expensed
(SPL)
Development costs
capitalised (If recognition criteria in paragraph 57 are met, otherwise
expensed.) (SFP)
Why?
Thus:
Research: Expense
Development: Capitalise as intangible asset (If criteria in IAS38.57
are met, see next slide.)
11 INTERNALLY GENERATED IA: RESEARCH AND DEVELOPMENT COSTS
TB 15.6.2.1
IAS 38.57
BUT: before you can recognise the development costs as an intangible
asset, the following recognition criteria should be satisfied:
1) Normal recognition criteria.
2) Technical feasibility should be of such a nature that the product will be
ready for sale or use after development is complete.
3) Intention to complete and sell/use.
4) Ability to complete and sell/use.
5) Should be able to establish how probable future economic benefits
will be generated.
6) Availability of sources to be able to complete and sell/use the asset.
7) Expenditure with respect to the development phase can be measured
reliably.
Thus: if there is uncertainty with respect to the economic benefits that will
be generated or if the cost cannot be measured reliably, then all expenditure
will be recognised as an expense.
12 INTERNALLY GENERATED IA: RESEARCH AND DEVELOPMENT COSTS
TB 15.6.2.1
IAS 38.66 - 67
What if we cannot distinguish between research and development?
Prudence – everything recognised as an expense! 🤔 Conceptual
FW, Prudence?
Which costs may be capitalised?
Only the directly attributable costs with respect to the development phase,
e.g. material and services used, employee benefits arising from
generation of IA, fees to register legal right and amortisation of patents
and licences used to generate the IA.
The departmental head spent 15% of his time on Project I and 10% on Project II.
Required: Calculate the amount that can be capitalised as development cost?
Test yourself!
16 EXAMPLE: RESEARCH AND DEVELOPMENT COSTS
TB 15.6.2.1
Project I:
The activity is classified as research and all costs are recognised as
expenses. No amount is capitalised.
Project II:
This project has met all the recognition criteria from the beginning of the year
and therefore all directly attributable development costs can be capitalised,
i.e. 620 + 320 + (10% × 400) + 410 + 60 = 1 450 000.
TB 15.7
Subsequent measurement
Choose between:
Cost model (Cost – Accumulated amortisation and impairment losses); or
Revaluation model (Fair value – accumulated amortisation and impairment
losses since revaluation date). (N/A, excluded for this year)
Test yourself!
21 MEASUREMENT: AMORTISATION OVER USEFUL LIFE IAS 38.99
TB 15.7.1
R R
31 July 20.12 – 31 December 20.12
Dr Intangible asset – Development cost (SFP) 150
000
Cr Bank (SFP)
150 000
Recognise development cost as an intangible asset
31 December 20.13
Dr Amortisation (P/L)*
30 000
*The amortisation of the development
Cr Accumulated
costs can also amortisation
be debited to(SFP)
cost of
30 000to the manufacture
sales since it relates
of thefor
Amortisation of development costs new product.
20.13 (150 000/5)
22 MEASUREMENT: AMORTISATION OVER USEFUL LIFE TB 15.7.1
TB 15.7.3.1
Useful life:
Intangible assets can either have:
A finite useful life, or Finite = Limited /
restricted
Indefinite useful life (N/A)
Factors that may influence the useful life of intangible assets include:
the expected use;
Economic factors:
the useful life of similar assets; determine period
(Future economic
technological or other types of obsolescence;
benefit); Legal
maintenance expenditure; factors: restrict
period.
actions by competitors;
legal or similar contractual limits on the use of the asset;
whether the useful life is dependent on the useful life of other assets;
the stability of the industry in which the asset operates; and
changes in market demand for services or products generated by the
intangible asset.
24 MEASUREMENT: AMORTISATION PERIOD IAS 38.94 & 96
TB 15.7.3.1
For intangible assets with a finite useful life:
TB 15.7.3.2
Amortisation method
The entity shall choose an amortisation method that reflects the pattern
in which it expects to consume the asset’s future economic benefits,
such as the:
If the entity cannot determine that pattern reliably, it shall use the
straight-line method.
Changes to residual value,
amortisation method or period is a
change in accounting estimate
(IAS 8). Come back after you
have done IAS 8.
IAS 38.8 & 100 - 104
26 MEASUREMENT: RESIDUAL VALUE TB 15.7
The residual value may in some instances exceed the carrying amount.
Then: cease the amortisation until the residual value has decreased to
below the carrying amount
This should be evaluated annually
27 MEASUREMENT: RESIDUAL VALUE TB 15.7.3.3
Test yourself!
28 MEASUREMENT: RESIDUAL VALUE TB 15.7.3.3
R
Carrying amount
27 000
Estimated residual value
(6 000)
Amortisation amount
21 000
Useful life
3 years
Amortisation (R21 000/3)
7 000
29 MEASUREMENT: RESIDUAL VALUE TB 15.7.3.3
R
Carrying amount (R27 000 – R7 000)
20 000
New estimated residual value
(11 000)
New amortisation amount
9 000
Useful life (remaining) The change in the residual value
2 isyears
a change in estimate – IAS 8
(prospectively). We will cover
Amortisation (R9 000/2) this later in the year.
4 500
30
IAS 38 Intangible
assets
Lecture 2: Part B
Impairment (IAS 36), derecognition
and Income Tax (IAS 12)
IAS 38.111
31 IMPAIRMENT TB 15.8
Internally generated intangible assets that are not yet available for use: Test
for impairment at least annually, even if no indication of impairment exists.
Therefore, for research and development cost the expected future
economic benefits of the asset (recoverable amount) should be compared
to the asset’s carrying amount at the end of each financial year (test for
impairment).
If any criteria for the capitalisation of development costs no longer apply
the intangible asset should be written off immediately.
However, when subsequently persuasive evidence exists that the
circumstances (that resulted in the write-down) no longer exist, the asset
may be reinstated. Taking into account amortisation in accordance with
the original plan of amortisation for the period of the write down.
Derecognise when:
Asset is sold (on disposal), or
No future economic benefits are expected (from expected use /
disposal)
If a part is replaced, recognise the cost of replacement and derecognise
the carrying amount of the replaced part.
Test yourself!
35 EXAMPLE: IMPAIRMENT AND RETIREMENT TB 15.9
TEMP DT ASSET/
DIFFERENCE (LIABILITY)
DESCRIPTION CA TB
R R R R
Development costs* 270 000 240 000 30 000 (8 400)
* Calculations:
CA: R320 000 – R50 000
TB: R320 000 – (R320 000 x 25%)
During the year, a company paid for research costs of R10 000 in cash and
immediately recognised it as an expense in the statement of profit or loss and
other comprehensive income in terms of IAS 38. Assume SARS allows such
research costs to be deducted over three years on a 50/30/20 basis.
TEMP DT ASSET/
DESCRIPTION CA TB DIFFERENCE (LIABILITY)
R R R R
Research costs* - 5 000 (5 000) 1 400
* Calculations:
TB: R10 000 – (R10 000 x 50%)
From the above it can be seen that the SARS allows an additional 50%
deduction above the normal 100% deduction, as for accounting purposes, for
the expense. This will give rise to the following difference:
Current tax calculation
Profit before tax
1 000 000
Non-taxable / Non-deductible items
Additional tax deduction for research costs (R200 000 x 50%) (100
000)
Temporary differences
xxx
xxxx
Taxable income
xxxx
IFRS 9 IAS 38
What would be the appropriate accounting treatment for
cryptocurrencies like Bitcoin? Assume this to be a discussion
question in the next test.
• Classification
• Recognition
• Measurement
• Presentation and disclosure
Classification
43
44 Answer and class discussion
Without physical
Identifiable Non-monetary asset
substance
45 Answer
Because currency is not a right to receive cash at a determinable
amount due to crypto being such a volatile market, it can not be
classified under IFRS 9 and IAS 32.
Please do the questions on your own, then mark them and correct your
own work. Make notes on errors made and correct your thinking pattern
where necessary.
Thank you!